Outcomes for patients with extraprostatic prostate cancer treated with trimodality therapy, including brachytherapy, external beam radiotherapy, and hormone therapy-Reference-Cited by-同舟云学术

Outcomes for patients with extraprostatic prostate cancer treated with trimodality therapy, including brachytherapy, external beam radiotherapy, and hormone therapy

Published:2011-07 Issue:4 Volume:10 Page:261-268
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Carpenter Todd J.,Forsythe Kevin,Kao Johnny,Stone Nelson N.,Stock Richard G.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference48 articles.

1. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer;Kattan;J Natl Cancer Inst,1998

2. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D’Amico;JAMA,1998

3. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer;Kattan;J Clin Oncol,2000

4. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer;D’Amico;J Clin Oncol,1999

5. Adenocarcinoma of the prostate invading the seminal vesicle: Prognostic stratification based on pathologic parameters;Epstein;Urology,2000

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer;Current Oncology;2023-09-01

2. Radiation treatment planning study to investigate feasibility of delivering Immunotherapy in Combination with Ablative Radiosurgery to Ultra‐High DoSes (ICARUS);Journal of Applied Clinical Medical Physics;2021-02-24

3. Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancer;Brachytherapy;2018-11

4. Five-year effectiveness of low-dose-rate brachytherapy: comparisons with nomogram predictions in patients with non-metastatic prostate cancer presenting significant control of intra- and periprostatic disease;Journal of Contemporary Brachytherapy;2018

5. High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypofractionated regimens and clinical outcomes;Radiotherapy and Oncology;2017-07